Fig. 4 | Scientific Reports

Fig. 4

From: Prognostic impact of extracellular volume fraction derived from equilibrium contrast-enhanced CT in HCC patients receiving immune checkpoint inhibitors

Fig. 4

Heatmap showed the relationship between tumor, liver ECV fraction and clinical characteristics with OS for each patient. ECV extracellular volume, HBV hepatitis B virus, ICIs immune checkpoint inhibitors, PVTT portal vein tumor thrombosis, BCLC Barcelona clinic liver cancer, ECOG PS eastern cooperative oncology group physical status, NLR neutrophil to lymphocyte ratio, PLR platelet to lymphocyte ratio, ALT alanine transaminase, AST aspartate transaminase, TB total bilirubin, PT prothrombin time, AFP alpha-fetoprotein.

Back to article page